Potential benefit of high-dose intravenous vitamin C for coronavirus disease 2019 pneumonia

Chin Med J (Engl). 2022 Jan 5;135(1):23-25. doi: 10.1097/CM9.0000000000001746.
No abstract available

MeSH terms

  • Administration, Intravenous
  • Ascorbic Acid / therapeutic use
  • COVID-19*
  • Humans
  • Pneumonia*
  • SARS-CoV-2

Substances

  • Ascorbic Acid